Cempra (CEMP) in Focus: Stock Rises 11.4% in Session – Tale of the Tape

ZacksCempra, Inc. (CEMP) was a big mover last session, as the company saw its shares rise more than 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $13.22 to $14.54 in the past one-month time frame.

None of the estimates for this med-drugs stock were revised over the past 30 days. The Zacks Consensus Estimate however moved up over the same time frame, suggesting that more solid trading could be ahead for Cempra. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.

Cempra has a Zacks Rank #2 (Buy), while its Earnings ESP is 0.00%

Investors interested in the sector may also consider stocks like Biodel Inc. (BIOD), IGI, Laboratories, Inc. (IG) and Lannett Company, Inc. (LCI). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Be the first to comment

Leave a Reply